½ÃÀ庸°í¼­
»óǰÄÚµå
1585791

±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå : ±¸¼º¿ä¼Ò, ±â¼ú, ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Brachytherapy Treatment Planning System Market by Component (Auto-Contouring Software, DICOM-RT Software, Multi-Modality Software), Technology (3D Image Reconstruction, Image Registration, In-Room Imaging), Applications - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ 8¾ï 763¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 9¾ï 539¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 12.50%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 18¾ï 4,215¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹æ»ç¼± Ä¡·á °èȹ ½Ã½ºÅÛ(BTPS) ½ÃÀåÀº ¹æ»ç¼± Ä¡·áÀÇ ÇÑ ÇüÅÂÀÎ ¹æ»ç¼± Ä¡·áÀÇ °èȹ ¹× ½ÇÇà¿¡ ÇÊ¿äÇÑ ¼ÒÇÁÆ®¿þ¾î ¹× ±â¼ú ¼Ö·ç¼Ç¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖÀ¸¸ç, BTPSÀÇ Çʿ伺Àº ¹æ»ç¼±À» Á¤È®ÇÏ°í ±¹¼ÒÀûÀ¸·Î Á¶»çÇÏ¿© ÁÖº¯ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϰí Ä¡·á È¿°ú¸¦ ³ôÀ̱â À§ÇÑ Çʿ伺¿¡¼­ ºñ·ÔµË´Ï´Ù. Ä¡·á È¿°ú¸¦ ³ôÀ̱â À§ÇÑ Çʿ伺¿¡¼­ ºñ·ÔµË´Ï´Ù. ÀÇ·á ºÐ¾ß¿¡¼­ ÀÌ ½Ã½ºÅÛÀº Àü¸³¼±¾Ï, ÀڱðæºÎ¾Ï, À¯¹æ¾Ï, ÇÇºÎ¾Ï µî ¾Ï¿¡ Àû¿ëµÇ¾î ÀÇ·áÁøÀÌ ¹æ»ç¼± ½Ãµå ¹× µµÆ÷±âÀÇ ÃÖÀû ¹èÄ¡¿Í ¹æ»ç¼± Á¶»ç·®À» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ÃÖÁ¾ »ç¿ëó´Â ÁÖ·Î º´¿ø, ¾Ï Ä¡·á ¼¾ÅÍ, ¹æ»ç¼± Ä¡·á Àü¹® Ŭ¸®´ÐÀÔ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¾Ï À¯º´·ü Áõ°¡, ¿µ»ó ±â¼úÀÇ ¹ßÀü, Ä¡·á °èȹ¿¡ ÀΰøÁö´ÉÀÇ ÅëÇÕ, ÃÖ¼Òħ½ÀÀû Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. Á¤È®µµ¸¦ ³ôÀ̰í, °èȹ ½Ã°£À» ´ÜÃàÇϸç, ȯÀÚ Ã³¸®·®À» Çâ»ó½Ãų ¼ö ÀÖ´Â AI ±â¹Ý ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖ´Â ±âȸ´Â ¹«±Ã¹«ÁøÇÕ´Ï´Ù. ¶ÇÇÑ ±â¾÷µéÀº °³ÀÎÈ­µÈ ÀÇ·áÀÇ ¿¬±¸ Áß½ÉÀÇ Çõ½ÅÀ» ÃËÁøÇϱâ À§ÇØ Çмú ±â°ü°úÀÇ Á¦ÈÞ¸¦ ¸ð»öÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ³ôÀº Ãʱ⠺ñ¿ë, ¼÷·ÃµÈ ¿î¿µÀÚÀÇ Çʿ伺, º¹ÀâÇÑ ±ÔÁ¦ µîÀÇ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ßµµ»ó±¹¿¡¼­ÀÇ ³·Àº ÀÎÁöµµ¿Í äÅ÷üµµ ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ º¸¾ÈÀ» º¸ÀåÇÏ°í ´Ù¾çÇÑ ½Ã½ºÅÛÀ» ÅëÇÕÇÏ¿© µ¥ÀÌÅ͸¦ ÅëÇÕÀûÀ¸·Î Ȱ¿ëÇÏ´Â °ÍÀº ±â¼úÀûÀ¸·Î ¾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å¿¡ °¡Àå ÀûÇÕÇÑ ºÐ¾ß·Î´Â ÀÓ»óÀÇ¿ÍÀÇ »óÈ£ÀÛ¿ëÀ» °³¼±Çϱâ À§ÇÑ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º °­È­, °³ÀÎÈ­µÈ Ä¡·á °èȹÀ» À§ÇÑ À¯Àüü µ¥ÀÌÅÍ ¼öÁý, ½Ç½Ã°£ Çù¾÷À» À§ÇÑ Å¬¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç °³¹ß µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ȯ°æÀº ±ÔÁ¦°¡ ¾ö°ÝÇϰí, Çõ½Å Áß½ÉÀÇ °æÀïÀÌ Ä¡¿­Çϸç, ÀμöÇÕº´(M&A)ÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖ¾î ²÷ÀÓ¾øÀÌ ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ÷´Ü ±â¼ú µµÀÔ°ú ºñ¿ë °ü¸®ÀÇ ±ÕÇüÀ» ¸ÂÃß´Â °ÍÀº ºñÁî´Ï½ºÀÇ Áö¼ÓÀûÀÎ ¼ºÀå°ú »õ·Î¿î ±âȸ Ȱ¿ëÀ» À§ÇØ ÇʼöÀûÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 8¾ï 763¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 9¾ï 539¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 18¾ï 4,215¸¸ ´Þ·¯
CAGR(%) 12.50%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°è ¾Ï À¯º´·ü ¹× ¾Ï °ü·Ã »ç¸Á·ü »ó½Â
    • ¾ÏÀÇ Á¤È®Çϰí Á¤¹ÐÇÑ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ¾Ï Ä¡·á ¼Ö·ç¼Ç¿¡¼­ ¹æ»ç¼± Ä¡·áÀÇ Ã¤Åà Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½Ã½ºÅÛ ÅëÇÕ¿¡ µû¸¥ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • »óȯ Á¤Ã¥ °³¼±
    • ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ ¹× ±ÙÁ¢Ä¡·á¹ý °³¼±
  • ½ÃÀå °úÁ¦
    • ¹æ»ç¼± ºÐ¾ßÀÇ ¼÷·ÃµÈ ÀÇ·á Àη ºÎÁ·

Portre's Five Forces: ±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¹æ»ç¼± Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

±ÙÁ¢Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ±ÙÁ¢Ä¡·á Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • Auto-Contouring Software
  • DICOM-RT Software
  • Multi-Modality Software
  • PET/CT Deformable Software

Á¦7Àå ±ÙÁ¢Ä¡·á Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°

  • 3D ¿µ»ó À籸¼º
  • ¿µ»ó µî·Ï
  • . In-Room Imaging

Á¦8Àå ±ÙÁ¢Ä¡·á Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

  • À¯¹æ¾Ï
  • ºÎÀΰú ¾Ï
  • Àü¸³¼±¾Ï

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ±ÙÁ¢Ä¡·á Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±ÙÁ¢Ä¡·á Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±ÙÁ¢Ä¡·á Ä¡·á °èȹ ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Accuray Incorporated
  • Adaptiiv Medical Technologies Inc.
  • C4 Imaging, LLC
  • Concure Oncology, Inc
  • Eckert & Ziegler Radiopharma GmbH
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Inomed Medizintechnik GmbH
  • IsoAid
  • Koninklijke Philips N.V.
  • Medical Targeting Technologies GmbH
  • MIM Software Inc.
  • Perspective Therapeutics
  • Prowess Inc.
  • RaySearch Laboratories AB
  • Seedos Ltd.
  • Shinva Medical Instrument Co., Ltd.
  • Siemens Healthineers AG
  • Standard Imaging, Inc.
  • Theragenics Corporation
LSH

The Brachytherapy Treatment Planning System Market was valued at USD 807.63 million in 2023, expected to reach USD 905.39 million in 2024, and is projected to grow at a CAGR of 12.50%, to USD 1,842.15 million by 2030.

The brachytherapy treatment planning system (BTPS) market focuses on software and technological solutions necessary for planning and delivering brachytherapy, a form of radiotherapy where a source of radiation is placed inside or next to the area requiring treatment. The necessity for BTPS arises from the need for precise and localized radiation delivery, minimizing damage to surrounding tissues and enhancing treatment efficacy. Clinically, these systems are applied in managing cancers such as prostate, cervical, breast, and skin cancer, where they aid healthcare providers in determining optimal placement and dosage for radiation seeds or applicators. End-use is predominantly in hospitals, cancer treatment centers, and specialized radiotherapy clinics. Key growth factors include the increasing prevalence of cancer, advancements in imaging technologies, integration of artificial intelligence in treatment planning, and rising demand for minimally invasive treatment methods. Opportunities abound in developing AI-driven software solutions that enhance precision and reduce planning time, thus improving patient throughput. Companies could also explore partnerships with academic institutions to drive research-focused innovations in personalized medicine. However, the market faces challenges like high initial costs, the need for skilled operators, and regulatory complexities. Limited awareness and adoption rates in developing regions also pose growth hurdles. Moreover, ensuring data security and integrating various systems for cohesive data use can be technologically challenging. The best areas for innovation include enhancing user interfaces to improve clinician interactions, incorporating genomic data for personalized treatment plans, and developing cloud-based solutions for real-time collaborations. In terms of market nature, it's heavily regulated, innovation-driven, and competitive with ongoing mergers and acquisitions contributing to a continually evolving landscape. Balancing cutting-edge technology implementation with cost management will be vital for sustained business growth and capitalizing on emerging opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 807.63 million
Estimated Year [2024] USD 905.39 million
Forecast Year [2030] USD 1,842.15 million
CAGR (%) 12.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brachytherapy Treatment Planning System Market

The Brachytherapy Treatment Planning System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer and cancer-related mortality globally
    • Growing demand for accurate and precise diagnosis of cancer
    • Increasing adoption of radiation therapy in cancer care solutions
  • Market Restraints
    • High cost associated with system integration
  • Market Opportunities
    • Improvement in reimbursement policies
    • Investments in R&D and improvements in brachytherapy treatment
  • Market Challenges
    • Shortage of skilled healthcare personnel in the radiology sector

Porter's Five Forces: A Strategic Tool for Navigating the Brachytherapy Treatment Planning System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brachytherapy Treatment Planning System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brachytherapy Treatment Planning System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brachytherapy Treatment Planning System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brachytherapy Treatment Planning System Market

A detailed market share analysis in the Brachytherapy Treatment Planning System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brachytherapy Treatment Planning System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brachytherapy Treatment Planning System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brachytherapy Treatment Planning System Market

A strategic analysis of the Brachytherapy Treatment Planning System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Treatment Planning System Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Adaptiiv Medical Technologies Inc., C4 Imaging, LLC, Concure Oncology, Inc, Eckert & Ziegler Radiopharma GmbH, Elekta AB, GE HealthCare Technologies Inc., Inomed Medizintechnik GmbH, IsoAid, Koninklijke Philips N.V., Medical Targeting Technologies GmbH, MIM Software Inc., Perspective Therapeutics, Prowess Inc., RaySearch Laboratories AB, Seedos Ltd., Shinva Medical Instrument Co., Ltd., Siemens Healthineers AG, Standard Imaging, Inc., and Theragenics Corporation.

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Treatment Planning System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Auto-Contouring Software, DICOM-RT Software, Multi-Modality Software, and PET/CT Deformable Software.
  • Based on Technology, market is studied across 3D Image Reconstruction, Image Registration, and In-Room Imaging.
  • Based on Applications, market is studied across Breast Cancer, Gynecologic Cancers, and Prostate Cancer.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer and cancer-related mortality globally
      • 5.1.1.2. Growing demand for accurate and precise diagnosis of cancer
      • 5.1.1.3. Increasing adoption of radiation therapy in cancer care solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with system integration
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvement in reimbursement policies
      • 5.1.3.2. Investments in R&D and improvements in brachytherapy treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled healthcare personnel in the radiology sector
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Brachytherapy Treatment Planning System Market, by Component

  • 6.1. Introduction
  • 6.2. Auto-Contouring Software
  • 6.3. DICOM-RT Software
  • 6.4. Multi-Modality Software
  • 6.5. PET/CT Deformable Software

7. Brachytherapy Treatment Planning System Market, by Technology

  • 7.1. Introduction
  • 7.2. 3D Image Reconstruction
  • 7.3. Image Registration
  • 7.4. In-Room Imaging

8. Brachytherapy Treatment Planning System Market, by Applications

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Gynecologic Cancers
  • 8.4. Prostate Cancer

9. Americas Brachytherapy Treatment Planning System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brachytherapy Treatment Planning System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brachytherapy Treatment Planning System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Adaptiiv Medical Technologies Inc.
  • 3. C4 Imaging, LLC
  • 4. Concure Oncology, Inc
  • 5. Eckert & Ziegler Radiopharma GmbH
  • 6. Elekta AB
  • 7. GE HealthCare Technologies Inc.
  • 8. Inomed Medizintechnik GmbH
  • 9. IsoAid
  • 10. Koninklijke Philips N.V.
  • 11. Medical Targeting Technologies GmbH
  • 12. MIM Software Inc.
  • 13. Perspective Therapeutics
  • 14. Prowess Inc.
  • 15. RaySearch Laboratories AB
  • 16. Seedos Ltd.
  • 17. Shinva Medical Instrument Co., Ltd.
  • 18. Siemens Healthineers AG
  • 19. Standard Imaging, Inc.
  • 20. Theragenics Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦